Study of Monzosertib In Patients With R/R AML Or High-Risk Myelodysplastic Syndrome

Study of Monzosertib In Patients With R/R AML Or High-Risk Myelodysplastic Syndrome
Conditions: Acute Myeloid Leukemia (AML); Myelodysplastic Syndrome

Interventions: Drug: Monzosertib; Drug: Posaconazole; Drug: Isavuconazole

Sponsors: M.D. Anderson Cancer Center; Carna Biosciences, Inc.

Not yet **RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

August 24, 2026Comments OffClinicalTrials.gov | Oncology Clinical Trials | Oncology Studies | US National Library of Medicine
Comments